Liège
Belgium
9
2022-12-29
8
2023-09-19
These are the the leading inventors for applications assigned to IMCYSE SA:
IMCYSE SA based in Liège, BE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Peptides and methods for the treatment of diabetes
#2 | 2020-12-31 ✅ Patent 11,407,795 granted on 2022-08-09Peptides and methods for the treatment of diabetes
#3 | 2020-12-24 ✅ Patent 12,023,384 granted on 2024-07-02Immunogenic peptides comprising an MHC class II T cell epitope and a redox motif
#4 | 2020-10-08 ✅ Patent 11,718,650 granted on 2023-08-08Immunogenic peptides and their use in immune disorders
#5 | 2020-04-02 ✅ Patent 11,226,332 granted on 2022-01-18Method for the detection, preparation and depletion of CD4+ t lymphocytes
#6 | 2019-11-21 ✅ Patent 10,808,016 granted on 2020-10-20Peptides and methods for the treatment of diabetes
#7 | 2019-04-11 ✅ Patent 11,485,768 granted on 2022-11-01Immunogenic CD1d binding peptides
#8 | 2018-09-13 ✅ Patent 11,787,849 granted on 2023-10-17Methods and compounds for eliminating immune responses to therapeutic agents
#9 | 2018-08-16NOVEL IMMUNOGENIC PEPTIDES
Also check out IMCYSE SA's (Liège, Belgium) applicant profile with 11 patent applications submitted.
138325 ⎘